Terms: = Colorectal cancer AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA AND Treatment
3 results:
1. Inactivating mutations of class II transactivator (ciita) gene in gastric and colorectal cancers.
Son HJ; Choi EJ; Yoo NJ; Lee SH
Pathol Res Pract; 2020 Oct; 216(10):153110. PubMed ID: 32853948
[TBL] [Abstract] [Full Text] [Related]
2. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
[TBL] [Abstract] [Full Text] [Related]
3. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients.
de Bruin EC; van de Velde CJ; van Krieken JH; Marijnen CA; Medema JP
Clin Cancer Res; 2008 Feb; 14(4):1073-9. PubMed ID: 18281539
[TBL] [Abstract] [Full Text] [Related]
